What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO)
Published . Updated .
What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO) Simply Wall Street
Directly affected
- HALO Halozyme Therapeutics
Named in this report.
Indirectly affected
- LOHA ROUNDHILL ETF TR HALO ETF
GA selected LOHA as a RELATED security because its canonical security name directly matches this event's themes: halo. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO) Simply Wall Street
Source: Simply Wall Street
How far Halozyme Therapeutics (HALO) has moved since 11 Oct 2026
Since the first closing price after “What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO),” Halozyme Therapeutics (HALO) is +10.26%. The S&P 500 fund (SPY) is -1.47% over the same days, a +11.73% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.63% | final price |
| GLD | the next day | -0.76% | final price |
| GLD | two days later | -2.24% | final price |
| GLD | three days later | -0.50% | final price |
| GLD | three days earlier | -2.27% | final price |
| GLD | five days earlier | -1.32% | final price |
| Halozyme Therapeutics (HALO) | that day | +0.60% | final price |
| Halozyme Therapeutics (HALO) | the next day | -0.72% | final price |
| Halozyme Therapeutics (HALO) | two days later | +5.80% | final price |
| Halozyme Therapeutics (HALO) | three days later | +10.04% | final price |
| Halozyme Therapeutics (HALO) | three days earlier | +0.34% | final price |
| Halozyme Therapeutics (HALO) | five days earlier | -1.91% | final price |
| QQQ | that day | -0.70% | final price |
| QQQ | the next day | -1.01% | final price |
| QQQ | two days later | -2.97% | final price |
| QQQ | three days later | -3.07% | final price |
| QQQ | three days earlier | +0.86% | final price |
| QQQ | five days earlier | +0.64% | final price |
| SPY | that day | -0.06% | final price |
| SPY | the next day | -0.06% | final price |
| SPY | two days later | -1.14% | final price |
| SPY | three days later | -0.87% | final price |
| SPY | three days earlier | -0.17% | final price |
| SPY | five days earlier | -0.45% | final price |
| TLT | that day | +0.08% | final price |
| TLT | the next day | +0.50% | final price |
| TLT | two days later | +1.18% | final price |
| TLT | three days later | +2.60% | final price |
| TLT | three days earlier | -1.03% | final price |
| TLT | five days earlier | -1.09% | final price |
Official trades in Halozyme Therapeutics (HALO) around 11 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Halozyme Therapeutics (HALO)
Companies tied to this story
- HALO Halozyme Therapeutics
For “What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO),” Halozyme Therapeutics (HALO) is linked, with no stored direction, medium confidence. Reason on file: GA selected HALO as a RELATED security because its canonical security name directly matches this event's themes: therapeutics, halozyme. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- LOHA Roundhill Etf Tr Halo Etf
For “What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO),” Roundhill Etf Tr Halo Etf (LOHA) is linked, with no stored direction, medium confidence. Reason on file: GA selected LOHA as a RELATED security because its canonical security name directly matches this event's themes: halo. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Halozyme Therapeutics (HALO)
The 11 Oct 2026 story “What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO)” names Halozyme Therapeutics (HALO) because of this story.
What ties Halozyme Therapeutics (HALO) to the headline is this: GA selected HALO as a RELATED security because its canonical security name directly matches this event's themes: therapeutics, halozyme. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, Roundhill Etf Tr Halo Etf (LOHA), is listed for a different reason: GA selected LOHA as a RELATED security because its canonical security name directly matches this event's themes: halo. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Halozyme Therapeutics (HALO), and the dates in the story
HALO traded between 105.54 and 123.60 across 20 sessions. The latest close on file is 122.50. LOHA traded between 24.63 and 25.91 across 12 sessions. The latest close on file is 25.68.
What the saved facts support for Halozyme Therapeutics (HALO)
24 out of 100
“What Investors Are Trying To Figure Out About Halozyme Therapeutics (HALO)” scores 24 out of 100. The score uses 2 sources, a -0.66% difference versus the S&P 500 (SPY), and 2 linked companies.